Revision history of "PRECLINICAL AND CLINICAL DEVELOPMENT OF ARGINASE INHIBITOR FOR ANTICANCER IMMUNOTHERAPY" (Q77977)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 October 2024

  • curprev 05:5305:53, 13 October 2024DG Regio talk contribs 86,401 bytes −22 Changed label, description and/or aliases in pt
  • curprev 05:5305:53, 13 October 2024DG Regio talk contribs 86,423 bytes +22 Set a claim value: summary (P836): Número de referência do programa de ajuda: SA.41471(2015/X) Objetivo do auxílio público: Artigo 25.o do Regulamento (CE) n.o 651/2014, de 17 de junho de 2014, que declara certos tipos de auxílio compatíveis com o mercado interno, em aplicação dos artigos 107.o e 108.o do Tratado (JO L EU L 187/1 de 26.6.2014). O objetivo do projeto é desenvolver ainda mais o candidato clínico OncoArendi OATD-02, o inibidor potente da arginase, uma enzima que permite...

20 March 2024

12 January 2024

6 July 2023

11 June 2023

24 May 2023

2 March 2023

  • curprev 22:2122:21, 2 March 2023DG Regio talk contribs 83,659 bytes +238 Changed label, description and/or aliases in lv, it, da, sk, de, ga, cs, et, mt, fi, bg, es, ro, sv, hr, pt, sl, nl, fr, hu, lt, el, and other parts

19 October 2022

17 October 2022

25 July 2022

  • curprev 19:5619:56, 25 July 2022DG Regio talk contribs 82,610 bytes +52,889 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

19 January 2022

15 January 2022

16 December 2021

7 December 2021

30 November 2021

  • curprev 14:3114:31, 30 November 2021DG Regio talk contribs 17,863 bytes +2,887 Created claim: summary (P836): Reference_Aid_programme: SA.41471(2015/X) But_public_aid: Article 25 du règlement (CE) no 651/2014 du 17 juin 2014 déclarant certaines catégories d’aides compatibles avec le marché intérieur en application des articles 107 et 108 du traité (JO URZ. EU L 187/1 du 26.6.2014). L’objectif du projet est de développer le candidat clinique OATD-02 développé par OncoArendi, un inhibiteur de l’arginase potentiellement meilleur de sa classe, une enzyme qu...
  • curprev 14:3114:31, 30 November 2021DG Regio talk contribs 14,976 bytes +168 Changed label, description and/or aliases in fr: translated_label

29 October 2020

14 October 2020

  • curprev 10:5110:51, 14 October 2020DG Regio talk contribs 15,248 bytes +146 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 10:5110:51, 14 October 2020DG Regio talk contribs 15,102 bytes −128 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 10:5110:51, 14 October 2020DG Regio talk contribs 15,230 bytes +2,616 Created claim: summary (P836): Reference number of the aid programme: SA.41471(2015/X) Purpose of public aid: Article 25 of EC Regulation No 651/2014 of 17 June 2014 declaring certain types of aid compatible with the internal market in the application of Articles 107 and 108 of the Treaty (OJ L. I'm sorry. EU L 187/1 of 26.06.2014). The aim of the project is to further develop the OncoArendi clinical candidate OATD-02, the potently best-in-class arginase inhibitor, an enzyme...
  • curprev 10:5110:51, 14 October 2020DG Regio talk contribs 12,614 bytes −2,106 Removed claim: summary (P836): Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The purpose of the project is to further develop the OATArendi clinical candidate OATD-02, which is likely to be the best in his class of an enzyme, an enzym...

25 September 2020

23 September 2020

15 July 2020

9 June 2020

6 June 2020

26 March 2020

4 March 2020

  • curprev 08:5508:55, 4 March 2020DG Regio talk contribs 13,007 bytes +2,106 Created claim: summary (P836): Reference_reference_programme_aids:SA.41471 (2015/X) _public:Article 25 of Commission Regulation (EC) No 651/2014 of 17 June 2014 declaring certain categories of aid compatible with the internal market in the application of Article 107 and 108 of the Treaty (OJ(OJ LEU L 187/1, 26.06.2014).The purpose of the project is to further develop the OATArendi clinical candidate OATD-02, which is likely to be the best in his class of an enzyme, an enzyme...

18 February 2020

8 February 2020

31 January 2020

13 January 2020